Inventiva S.A. Form 6-K Summary
Business Context and Reporting Period
Inventiva S.A., a French biotechnology company, furnished this Form 6-K for April 2023. The filing is dated April 25, 2023 and reports the mailing of proxy materials to beneficial owners of the company’s American Depositary Shares.
Corporate and Financial Information
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics. It contains no financial statements or financial guidance.
Material Developments
- On April 25, 2023, Inventiva began mailing its proxy card and voting instructions to ADS holders.
- The materials relate to the company’s Ordinary and Extraordinary General Meeting scheduled for May 25, 2023, at 2:00 p.m. in Dijon, France.
- Exhibit 99.1 contains the proxy card, and Exhibit 99.2 contains voting instructions for beneficial owners of ADSs.
- The filing, excluding Exhibits 99.1 and 99.2, is incorporated by reference into Inventiva’s Form F-3 registration statement No. 333-258369, to the extent not superseded by subsequent filings.
Outlook, Risks, Contingencies, and Unusual Items
The filing does not provide management outlook, business guidance, risk updates, contingencies, or unusual financial items. The principal matter is the upcoming shareholder meeting and related voting process.
Important Facts to Verify
- Review the proxy card and voting instructions for the proposals submitted to shareholders.
- Confirm the date, time, and location of the May 25, 2023 Ordinary and Extraordinary General Meeting.
- Review subsequent SEC filings for meeting results, additional corporate actions, or financial updates.
- Note that Exhibits 99.1 and 99.2 were furnished rather than filed under Section 18 of the Exchange Act and are not incorporated by reference into other filings.